Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
As filed · AstraZeneca Pharma India Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
RegulatoryWatchNotablemateriality 61 out of 100
What happened
FactAstrazen has received an order from the Commissioner of Income-tax (Appeals) regarding the assessment year 2020-21, issued on November 26, 2025. The company is disclosing this information in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further details are provided in the attached Annexure.
Why it matters
CapitSignal interpretationLitigation creates a contingent liability that is not in reported profit until it crystallises.
Watch next
Fact- Amount claimed against the company
- Whether a provision has been made
- Next hearing or order date
Evidence
How CapitSignal classified this
- Reasoning:
- LITIGATION base 56; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%